High real-world adherence with long-acting cabotegravir plus rilpivirine (CAB+RPV LA) among people with HIV (PWH) in the United States (US) HIV DART 2024 Jan 9 Written By Irina Kolobova Irina Kolobova Sign up to read this post Join Now
High real-world adherence with long-acting cabotegravir plus rilpivirine (CAB+RPV LA) among people with HIV (PWH) in the United States (US) HIV DART 2024 Jan 9 Written By Irina Kolobova Irina Kolobova Sign up to read this post Join Now